![]() |
Donna Ambrosino, MDMore than 30 years developing vaccines and biologics for infectious diseases
|
![]() |
Chuck Finn, PhDMore than 30 years of product development and regulatory experience covering a wide range of product types and therapeutic indications. Experience includes FDA – CBER, biopharma and CRO industry
|
![]() |
Mark Leney, PhDOver 10 years of experience in the development, manufacturing, testing and clinical trials of both investigational and commercial vaccine and biologic products
|
Nnamdi Nwachukwu, MSc, MS, RACMore than 15 years of global experience in regulatory strategy, CMC, operations, clinical risk management, and market access strategies for biologics, vaccines, immunotherapies, and digital technologies.
|
![]() |
Neil Sandler, MBAOver 30 years of investment and finance experience including > $1B in biopharma development
|
![]() |
George Siber, MDMore than 35 years developing vaccines and therapeutic programs for infectious diseases
|
![]() |
D Nigel Thomas, PhDMore than 25 years of experience in global clinical development with focus on operational excellence.
|
![]() |
Larissa N. ZemoMs. Zemo has more than 20 years of experience in drug development services, including various program management and leadership positions.
|